According to Tarsus Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$3.38. In 2022 the company made an earnings per share (EPS) of -$2.55 a decrease over its 2021 EPS that were of -$0.66.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.38 | 32.55% |
2022 | -$2.55 | 286.36% |
2021 | -$0.66 | -58.29% |
2020 | -$1.58 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -35.50% | ๐บ๐ธ USA |